TuisABDXF • OTCMKTS
add
Abingdon Health PLC
Vorige sluiting
$0,070
Jaarwisseling
$0,070 - $0,070
Markkapitalisasie
11,28 m GBP
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
LON
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (GBP) | Des. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 1,55 m | 28,38% |
Bedryfskoste | 1,71 m | 24,54% |
Netto inkomste | -1,26 m | -109,21% |
Netto winsgrens | -81,48 | -62,96% |
Wins per aandeel | — | — |
EBITDA | -982,00 k | -66,58% |
Effektiewe belastingkoers | 4,25% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (GBP) | Des. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 3,67 m | 83,73% |
Totale bates | 9,82 m | 103,69% |
Totale aanspreeklikheid | 3,40 m | 13,07% |
Totale ekwiteit | 6,42 m | — |
Uitstaande aandele | 375,95 m | — |
Prys om te bespreek | 3,50 | — |
Opbrengs op bates | -28,39% | — |
Opbrengs op kapitaal | -37,53% | — |
Kontantvloei
Netto kontantverandering
| (GBP) | Des. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -1,26 m | -109,21% |
Kontant van bedrywe | -1,10 m | -82,99% |
Kontant van beleggings | -570,50 k | -28 625,00% |
Kontant van finansiering | 2,78 m | 13 044,19% |
Netto kontantverandering | 1,12 m | 280,21% |
Beskikbare kontantvloei | -547,19 k | -65,00% |
Meer oor
Abingdon Health is a leading international developer, manufacturer and distributor of lateral flow assay diagnostic tests, sometimes called rapid tests, lateral flow immunoassays, lateral flow tests or quick tests. Since its formation in 2008, Abingdon Health has developed and manufactured lateral flow rapid tests across multiple industries. Headquartered in York, with sites in Doncaster and Madison, USA. Wikipedia
HUB
Gestig
01 Jan. 2008
Webwerf
Werknemers
113
